Parametric Portfolio Associates’s Phibro Animal Health PAHC Stock Holding History
Bought
Maintained
Sold
Other funds holding PAHC
FMI
HA
Parametric Portfolio Associates's PAHC Position: Q1 2022 in Review
Parametric Portfolio Associates increased its Phibro Animal Health (PAHC) stake by 14% in Q1 2022, buying an estimated $295K and bringing the position to 117,493 shares worth $2.34M. The position accounts for ﹤0.01% of the portfolio, ranked #2336.
Parametric Portfolio Associates first reported a position in PAHC in Q4 2014 and has held it in 30 quarters since. The position peaked at $4.85M in Q2 2018. 153 funds tracked by Wall St. Rank hold PAHC as of Q1 2022.
- Parametric Portfolio Associates held 117,493 shares of Phibro Animal Health worth $2.34M as of Q1 2022.
- Parametric Portfolio Associates bought 14,604 Phibro Animal Health shares in Q1 2022, an estimated $295K.
- Phibro Animal Health made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2336 holding.
- Parametric Portfolio Associates first reported a position in Phibro Animal Health in Q4 2014 and has held it in 30 quarters since.
- Parametric Portfolio Associates's Phibro Animal Health position peaked at $4.85M in Q2 2018.
- 153 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2022.
Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.